The 46 rating InvestorsObserver gives to Tonix Pharmaceuticals Holding Corp (TNXP) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 47 percent of stocks in the Biotechnology industry, TNXP’s 46 overall rating means the stock scores better than 46 percent of all stocks.
Click Here to get the full Stock Score Report on Tonix Pharmaceuticals Holding Corp (TNXP) Stock.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Tonix Pharmaceuticals Holding Corp Stock Today?
Tonix Pharmaceuticals Holding Corp (TNXP) stock is up 25.16% while the S&P 500 has fallen -0.24% as of 10:49 AM on Friday, Jan 24. TNXP has gained $0.35 from the previous closing price of $1.39 on volume of 11,197,684 shares. Over the past year the S&P 500 is higher by 25.55% while TNXP has fallen -90.84%. TNXP lost -$88.49 per share the over the last 12 months.
